Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su-Pin Choo

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2022
Atezolizumab and bevacizumab for HCC in the real worldSu Pin Choo, Pierre Nahon
Gastrointestinal Cancer Research : GCR|March 5, 2009
Responding to the rising incidence of hepatocellular carcinoma with targeted therapySu-Pin Choo, Alan P Venook
Onkologie|September 25, 2007
An alternative therapy for patients with hepatic impairment?Su-Pin Choo, Alan P Venook
Cancers|December 11, 2019
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersDavid Tai, Su Pin Choo, Valerie Chew
Annals of Translational Medicine|January 25, 2021
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?Matthew C H Ng, Su Pin Choo
Journal of Gastrointestinal Cancer|November 9, 2010
Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST)Grace Tan, Melissa Teo, Su Pin Choo
International Journal of Hepatology|October 14, 2011
Targeted therapy in hepatocellular carcinomaClarinda W L Chua, Su Pin Choo
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Targeted therapies in the treatment of gastric cancerJoanne Ngeow, Iain Beehuat Tan, Su Pin Choo
Palliative Medicine|December 16, 2006
The not so innocuous abdominal tapChee-Wai Wong, Su-Pin Choo, Kian-Fong Foo
Diseases (Basel, Switzerland)|September 26, 2017
Clinical Development of c-MET Inhibition in Hepatocellular CarcinomaJoycelyn J X Lee, Jack J Chan, Su Pin Choo
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2022
Atezolizumab and bevacizumab for HCC in the real worldSu Pin Choo, Pierre Nahon
Gastrointestinal Cancer Research : GCR|March 5, 2009
Responding to the rising incidence of hepatocellular carcinoma with targeted therapySu-Pin Choo, Alan P Venook
Onkologie|September 25, 2007
An alternative therapy for patients with hepatic impairment?Su-Pin Choo, Alan P Venook
Cancers|December 11, 2019
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersDavid Tai, Su Pin Choo, Valerie Chew
Annals of Translational Medicine|January 25, 2021
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?Matthew C H Ng, Su Pin Choo
Journal of Gastrointestinal Cancer|November 9, 2010
Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST)Grace Tan, Melissa Teo, Su Pin Choo
International Journal of Hepatology|October 14, 2011
Targeted therapy in hepatocellular carcinomaClarinda W L Chua, Su Pin Choo
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Targeted therapies in the treatment of gastric cancerJoanne Ngeow, Iain Beehuat Tan, Su Pin Choo
Palliative Medicine|December 16, 2006
The not so innocuous abdominal tapChee-Wai Wong, Su-Pin Choo, Kian-Fong Foo
Diseases (Basel, Switzerland)|September 26, 2017
Clinical Development of c-MET Inhibition in Hepatocellular CarcinomaJoycelyn J X Lee, Jack J Chan, Su Pin Choo
Pageof 11